Search

everythinglearnresearchcommunity

for

Search:↓

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

Using adipose-derived stem cell media with minoxidil may help regrow hair in men with hair loss.

Combining platelet-rich plasma with other treatments may improve hair growth in people with hair loss, but more research is needed.

Using minoxidil with carboxytherapy is more effective for female pattern hair loss than minoxidil alone.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

More personalized and effective treatments for androgenetic alopecia are needed.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

The document concludes that personalized treatment plans for hair loss in Asian men are necessary and more research is needed to develop effective guidelines.

The authors suggest a method for hair transplantation in fibrosing alopecia pattern distribution to improve treatment outcomes and cover bald areas.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Botulinum toxin injections improved hair thinning in a woman with hair loss.

Women know more about androgenetic alopecia than men.

Androgenetic alopecia, or common baldness, is the main cause of hair loss in men due to shrinking hair follicles from hormones, and it's normal but can be a problem if it's too much or too early.

Dermatoscopy is useful for identifying different hair and scalp conditions and can reduce the need for biopsies.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Microneedling can effectively promote new hair growth in men with hair loss who didn't improve with traditional treatments.

Minoxidil can reduce functions related to androgen receptors.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Substance from human umbilical cord blood cells promotes hair growth.

Balding hair follicle cells are smaller, grow less well, and need more effort to culture than non-balding cells.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Men with early-onset hair loss have more heart disease risk factors.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

Male mice are more susceptible to autism-like changes from valproic acid than female mice.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Men with androgenetic alopecia have different scalp oils and microbes compared to those without.

Female pattern baldness may indicate a higher risk of coronary artery disease.